Six critical errors that cost buyers money, deals, and clinical stability when acquiring autism therapy centers in the lower middle market.
Find Vetted Autism Therapy Center DealsAcquiring an ABA therapy center offers compelling recurring revenue and recession-resistant demand, but buyers routinely underestimate regulatory complexity, BCBA dependency risks, and Medicaid billing exposure. These six mistakes have killed deals and destroyed post-close value for unprepared acquirers.
Market Size
Approximately $2.5–$3.5 billion in the U.S. ABA therapy market, with broader autism services exceeding $10 billion annually
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Buyers overlook that a center dependent on one or two BCBAs faces immediate clinical and revenue collapse if those clinicians leave post-close, especially without non-compete or employment agreements in place.
How to avoid: Require signed multi-year employment agreements for all BCBAs before closing. Verify independent payor credentialing for each clinician. Assess whether clinical leadership depth exists beyond the selling owner.
Prior billing irregularities, upcoding, or undocumented sessions can trigger post-close overpayment recoupment demands from Medicaid, creating six-figure liabilities that buyers inherit without proper diligence.
How to avoid: Engage a healthcare billing compliance attorney to review three years of claims data, denial rates, and any prior audit correspondence before signing a purchase agreement.
Medicaid and commercial payor contracts are typically non-transferable. Buyers who close without initiating re-enrollment face a 60–180 day revenue gap while credentialing is reprocessed under the new ownership entity.
How to avoid: Begin payor re-enrollment applications during due diligence, not after closing. Negotiate a transition service agreement with the seller to maintain billing continuity under existing credentials during re-enrollment.
Sellers frequently present adjusted EBITDA with aggressive addbacks including owner compensation, personal expenses, and one-time items. Buyers accepting these figures without scrutiny often overpay by a full multiple turn.
How to avoid: Normalize financials using a market-rate BCBA clinical director salary replacing owner compensation. Require three years of tax returns and reconcile every addback to underlying documentation.
Many states require facility re-licensure under a new ownership entity, with timelines ranging from 30 to 180 days. Missing this step can trigger regulatory violations or payor contract suspension post-close.
How to avoid: Consult a healthcare regulatory attorney in the target state before LOI. Map all required license transfers, facility certifications, and payor notifications into a detailed closing checklist with realistic timelines.
Buyers accept reported client counts at face value without verifying active authorization hours, attendance rates, or lapsed authorizations that could reduce billable revenue by 20–30% in the first quarter post-close.
How to avoid: Request a current client census with authorization expiration dates, weekly scheduled hours, and attendance records. Flag clients with authorizations expiring within 90 days as an immediate post-close management priority.
Buyers submit SBA loan applications before independently verifying the Autism Therapy Center's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Autism Therapy Center needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Autism Therapy Center assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Autism Therapy Center acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
Yes. ABA therapy centers are SBA 7(a) eligible if the business has two or more years of operating history, positive cash flow, and clean financials. Expect a 10–15% equity injection and possible seller note to bridge any valuation gap.
Medicaid re-enrollment timelines vary by state but typically range from 60 to 180 days. Starting the process before closing and negotiating a transition billing arrangement with the seller is essential to avoid revenue disruption.
Lower middle market ABA centers typically trade at 3.5x to 6x EBITDA. Centers with multiple BCBAs, diversified payor mix, documented outcomes, and a strong waitlist command the higher end of that range.
Revenue and client retention can collapse rapidly without a credentialed BCBA on staff. Require a 6–12 month transition agreement and ensure at least one other BCBA is fully credentialed with all active payors before closing.
More Autism Therapy Center Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers